A recent paper shows licensing boards may take action for a professional’s behavior regardless of whether it is in the context of a professional setting.
Pfizer, J&J, Novartis and Sanofi tops in social media, say patients
Around a third of US adults use social media as a health resource, according to a survey by PricewaterhouseCoopers – whether seeking out medical info, sharing symptoms and experiences or rating drugs, devices, doctors, hospitals and health plans.